Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review.


Journal

Reviews in endocrine & metabolic disorders
ISSN: 1573-2606
Titre abrégé: Rev Endocr Metab Disord
Pays: Germany
ID NLM: 100940588

Informations de publication

Date de publication:
02 2022
Historique:
accepted: 22 12 2021
pubmed: 16 1 2022
medline: 15 3 2022
entrez: 15 1 2022
Statut: ppublish

Résumé

It is well-established that adipose tissue accumulation is associated with insulin resistance through multiple mechanisms. One major metabolic link is the classical Randle cycle: enhanced release of free fatty acids (FFA) from hydrolysis of adipose tissue triglycerides impedes insulin-mediated glucose uptake in muscle tissues. Less well studied are the different routes of this communication. First, white adipose tissue depots may be regionally distant from muscle (i.e., gluteal fat and diaphragm muscle) or contiguous to muscle but separated by a fascia (Scarpa's fascia in the abdomen, fascia lata in the thigh). In this case, released FFA outflow through the venous drainage and merge into arterial plasma to be transported to muscle tissues. Next, cytosolic triglycerides can directly, i.e., within the cell, provide FFA to myocytes (but also pancreatic ß-cells, renal tubular cells, etc.). Finally, adipocyte layers or lumps may be adjacent to, but not anatomically segregated, from muscle, as is typically the case for epicardial fat and cardiomyocytes. As regulation of these three main delivery paths is different, their separate contribution to substrate competition at the whole-body level is uncertain. Another important link between fat and muscle is vascular. In the resting state, blood flow is generally higher in adipose tissue than in muscle. In the insulinized state, fat blood flow is directly related to whole-body insulin resistance whereas muscle blood flow is not; consequently, fractional (i.e., flow-adjusted) glucose uptake is stimulated in muscle but not fat. Thus, reduced blood supply is a major factor for the impairment of in vivo insulin-mediated glucose uptake in both subcutaneous and visceral fat. In contrast, the insulin resistance of glucose uptake in resting skeletal muscle is predominantly a cellular defect.

Identifiants

pubmed: 35031911
doi: 10.1007/s11154-021-09708-3
pii: 10.1007/s11154-021-09708-3
pmc: PMC8873050
doi:

Substances chimiques

Insulin 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-50

Informations de copyright

© 2022. The Author(s).

Références

Metabolism. 1992 Nov;41(11):1242-8
pubmed: 1435298
J Clin Endocrinol Metab. 2002 Aug;87(8):3902-10
pubmed: 12161530
Metabolism. 2016 Aug;65(8):1038-48
pubmed: 26823198
Endocrinol Metab Clin North Am. 2008 Sep;37(3):713-31, x
pubmed: 18775360
Int J Obes (Lond). 2014 Aug;38(8):1019-26
pubmed: 24166067
Nature. 2021 Apr;592(7855):524-533
pubmed: 33883728
J Clin Invest. 1999 Jan;103(2):253-9
pubmed: 9916137
Curr Opin Clin Nutr Metab Care. 2002 Sep;5(5):481-7
pubmed: 12172470
J Clin Invest. 2004 Jun;113(11):1582-8
pubmed: 15173884
Nature. 2006 Dec 14;444(7121):860-7
pubmed: 17167474
Nature. 2020 Nov;587(7832):98-102
pubmed: 33116305
Circulation. 2018 Mar 27;137(13):1391-1406
pubmed: 29581366
J Clin Endocrinol Metab. 2016 Apr;101(4):1422-8
pubmed: 26871994
Diabetes. 1999 Jan;48(1):10-4
pubmed: 9892216
J Clin Endocrinol Metab. 2007 Mar;92(3):1023-33
pubmed: 17164304
Biol Res Nurs. 2009 Apr;10(4):356-73
pubmed: 19190032
J Clin Endocrinol Metab. 2014 Oct;99(10):E1870-6
pubmed: 24937536
Clin Sci (Lond). 1996 Dec;91(6):679-83
pubmed: 8976802
Cells. 2021 Aug 13;10(8):
pubmed: 34440850
N Engl J Med. 1999 Jul 22;341(4):240-6
pubmed: 10413736
Lancet. 1963 Apr 13;1(7285):785-9
pubmed: 13990765
Eur Radiol. 2019 Jul;29(7):3638-3646
pubmed: 30859284
Sports Med. 2018 Feb;48(2):269-288
pubmed: 29127602
Trends Endocrinol Metab. 2011 Nov;22(11):450-7
pubmed: 21852149
Physiol Rep. 2019 Feb;7(3):e13980
pubmed: 30740933
Diabetes. 2002 Aug;51(8):2467-73
pubmed: 12145159
Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E977-86
pubmed: 19458063
Front Physiol. 2020 Jan 22;10:1638
pubmed: 32038305
Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165838
pubmed: 32428560
Clin Sci (Lond). 1990 Oct;79(4):339-48
pubmed: 2171854
Eat Weight Disord. 2021 Apr 24;:
pubmed: 33895917
Obes Surg. 2019 Sep;29(9):2795-2805
pubmed: 31089967
Nutr Metab Cardiovasc Dis. 2011 Feb;21(2):79-85
pubmed: 21186102
J Lipid Res. 2005 Nov;46(11):2347-55
pubmed: 16150820
Am J Med. 2007 Feb;120(2 Suppl 1):S3-8; discussion S29-32
pubmed: 17296343
Am J Clin Nutr. 2018 Oct 1;108(4):749-758
pubmed: 30239554
Sci Rep. 2019 Nov 21;9(1):17315
pubmed: 31754142
Cell Metab. 2013 May 7;17(5):644-656
pubmed: 23583168
Am J Physiol Endocrinol Metab. 2003 Dec;285(6):E1282-8
pubmed: 12915396
J Clin Invest. 2000 Jul;106(2):171-6
pubmed: 10903330
Diabetologia. 2015 Jul;58(7):1646-55
pubmed: 25740696
Clin Sci (Lond). 2004 May;106(5):547-8
pubmed: 14686875
Mol Cell Biol. 2012 Jan;32(2):309-19
pubmed: 22083962
Physiol Rev. 2013 Jan;93(1):359-404
pubmed: 23303913
Int J Cardiol. 2007 Feb 7;115(2):272-3
pubmed: 16759715
Trends Pharmacol Sci. 2017 Jul;38(7):649-665
pubmed: 28551355
Int J Mol Sci. 2016 Nov 09;17(11):
pubmed: 27834856
Cell Metab. 2017 May 2;25(5):1027-1036
pubmed: 28467922
Diabetes. 2010 Jan;59(1):105-9
pubmed: 19846802
Cardiovasc Pathol. 2004 Mar-Apr;13(2):98-102
pubmed: 15033159
Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E166-74
pubmed: 16926380
Sci Rep. 2017 Aug 21;7(1):9007
pubmed: 28827671
J Magn Reson Imaging. 2012 Apr;35(4):899-907
pubmed: 22127958
Sci Rep. 2020 Jun 19;10(1):9973
pubmed: 32561768
Diabetes Obes Metab. 2018 Sep;20(9):2286-2290
pubmed: 29687584
Endocr Rev. 2000 Dec;21(6):697-738
pubmed: 11133069
Gastroenterology. 2007 Aug;133(2):496-506
pubmed: 17681171
Lancet Diabetes Endocrinol. 2019 Sep;7(9):715-725
pubmed: 31301983
J Clin Endocrinol Metab. 2015 Sep;100(9):3364-71
pubmed: 26186298
PLoS One. 2019 Apr 9;14(4):e0214660
pubmed: 30964881
Br J Radiol. 2012 Jan;85(1009):1-10
pubmed: 21937614
Am J Physiol Endocrinol Metab. 2000 May;278(5):E941-8
pubmed: 10780952
Life Sci. 2018 Jan 1;192:26-32
pubmed: 29155300
Am J Physiol Endocrinol Metab. 2017 Aug 1;313(2):E175-E182
pubmed: 28400411
Cell Metab. 2018 Jan 9;27(1):68-83
pubmed: 29320711
Circulation. 2011 Jul 5;124(1):67-76
pubmed: 21670228
J Biol Chem. 2002 Dec 27;277(52):50230-6
pubmed: 12006582
Diabetes. 2009 Mar;58(3):718-25
pubmed: 19074987
Diabetes. 2002 Jan;51(1):144-51
pubmed: 11756334
J Clin Invest. 2003 Dec;112(12):1796-808
pubmed: 14679176
Biomed Pharmacother. 2021 May;137:111315
pubmed: 33561645
J Clin Invest. 2017 Jan 3;127(1):74-82
pubmed: 28045400
Int J Obes (Lond). 2010 Jun;34(6):949-59
pubmed: 20065965
Nat Metab. 2019 Jan;1(1):86-97
pubmed: 31528845
J Clin Invest. 2020 Dec 1;130(12):6688-6699
pubmed: 33164985

Auteurs

Stefania Camastra (S)

Department of Clinical & Experimental Medicine, University of Pisa, Pisa, Italy. stefania.camastra@unipi.it.

Ele Ferrannini (E)

Institute of Clinical Physiology, CNR, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH